Cargando…

Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis

BACKGROUND: Schizophrenia is one of the most common, burdensome, and costly psychiatric disorders in adults worldwide. Antipsychotic drugs are its treatment of choice, but there is controversy about which agent should be used. We aimed to compare and rank antipsychotics by quantifying information fr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huhn, Maximilian, Nikolakopoulou, Adriani, Schneider-Thoma, Johannes, Krause, Marc, Samara, Myrto, Peter, Natalie, Arndt, Thomas, Bäckers, Lio, Rothe, Philipp, Cipriani, Andrea, Davis, John, Salanti, Georgia, Leucht, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6891890/ https://www.ncbi.nlm.nih.gov/pubmed/31303314 http://dx.doi.org/10.1016/S0140-6736(19)31135-3

Ejemplares similares

S204. REDUCTION OF ANTIPSYCHOTIC DOSES AND POLYPHARMACY: TWO COCHRANE REVIEWS
por: Leucht, Stefan, et al.
Publicado: (2020)

Effects of antipsychotics on heart rate in treatment of schizophrenia: a systematic review and meta-analysis
por: Huhn, Maximilian, et al.
Publicado: (2022)

Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
por: Bighelli, Irene, et al.
Publicado: (2022)

Antipsychotic dose reduction compared to dose continuation for people with schizophrenia
por: Rodolico, Alessandro, et al.
Publicado: (2022)

Reducing antipsychotic drugs in stable patients with chronic schizophrenia or schizoaffective disorder: a randomized controlled pilot trial
por: Huhn, Maximilian, et al.
Publicado: (2020)

Should ‘typical’, first-generation antipsychotics no longer be generally used in the treatment of schizophrenia?
por: Leucht, Stefan, et al.
Publicado: (2021)

Α Markov model for longitudinal studies with incomplete dichotomous outcomes
por: Efthimiou, Orestis, et al.
Publicado: (2016)

S235. MAINTENANCE TREATMENT WITH ANTIPSYCHOTIC DRUGS IN SCHIZOPHRENIA – SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
por: Schneider-Thoma, Johannes, et al.
Publicado: (2018)

T216. VARIATION IN SIDE EFFECTS TO ANTIPSYCHOTIC TREATMENT ACROSS SCHIZOPHRENIA SPECTRUM DISORDERS
por: Susanne Neumeier, Maria, et al.
Publicado: (2020)

Efficacy of clozapine compared with other second-generation antipsychotic drugs in patients with treatment-resistant schizophrenia: protocol for a systematic review and individual patient data meta-analysis of randomised controlled trials
por: Siafis, Spyridon, et al.
Publicado: (2023)

Metabolic side effects of antipsychotic drugs in individuals with schizophrenia during medium- to long-term treatment: protocol for a systematic review and network meta-analysis of randomized controlled trials
por: Schneider-Thoma, Johannes, et al.
Publicado: (2021)

Continuously updated network meta-analysis and statistical monitoring for timely decision-making
por: Nikolakopoulou, Adriani, et al.
Publicado: (2016)

Recent meta-analyses neglect previous systematic reviews and meta-analyses about the same topic: a systematic examination
por: Helfer, Bartosz, et al.
Publicado: (2015)

Agreement between ranking metrics in network meta-analysis: an empirical study
por: Chiocchia, Virginia, et al.
Publicado: (2020)

Extensions of the probabilistic ranking metrics of competing treatments in network meta‐analysis to reflect clinically important relative differences on many outcomes
por: Mavridis, Dimitris, et al.
Publicado: (2019)

Antipsychotic drugs and their effects on cognitive function: protocol for a systematic review, pairwise, and network meta-analysis
por: Feber, Lena, et al.
Publicado: (2023)

Synthesizing existing evidence to design future trials: survey of methodologists from European institutions
por: Nikolakopoulou, Adriani, et al.
Publicado: (2019)

CINeMA: Software for semiautomated assessment of the confidence in the results of network meta‐analysis
por: Papakonstantinou, Theodoros, et al.
Publicado: (2020)

Which first-generation antipsychotics should be “repurposed” for the treatment of schizophrenia
por: Leucht, Stefan, et al.
Publicado: (2022)

Estimating and visualising the trade-off between benefits and harms on multiple clinical outcomes in network meta-analysis
por: Chiocchia, Virginia, et al.
Publicado: (2023)

Answering complex hierarchy questions in network meta-analysis
por: Papakonstantinou, Theodoros, et al.
Publicado: (2022)

Estimating the sample size of sham-controlled randomized controlled trials using existing evidence
por: Siontis, George C.M., et al.
Publicado: (2022)

Long-Acting Injectable Antipsychotics in First-Episode Schizophrenia
por: Parellada, Eduard, et al.
Publicado: (2012)

Long-acting Injectable Antipsychotics in First-episode Schizophrenia
por: Jeong, Hyun-Ghang, et al.
Publicado: (2013)

The Longitudinal Course of Schizophrenia Across the Lifespan: Clinical, Cognitive, and Neurobiological Aspects
por: Heilbronner, Urs, et al.
Publicado: (2016)

The statistical importance of a study for a network meta-analysis estimate
por: Rücker, Gerta, et al.
Publicado: (2020)

Introducing the Treatment Hierarchy Question in Network Meta-Analysis
por: Salanti, Georgia, et al.
Publicado: (2021)

Blinding successfulness in antipsychotic trials of acute treatment for schizophrenia: a systematic review
por: Tajika, Aran, et al.
Publicado: (2023)

Characteristics of Networks of Interventions: A Description of a Database of 186 Published Networks
por: Nikolakopoulou, Adriani, et al.
Publicado: (2014)

A model for meta-analysis of correlated binary outcomes: The case of split-body interventions
por: Efthimiou, Orestis, et al.
Publicado: (2017)

Estimating the contribution of studies in network meta-analysis: paths, flows and streams
por: Papakonstantinou, Theodoros, et al.
Publicado: (2018)

T6. SECOND GENERATION ANTIPSYCHOTIC DRUGS AND MORTALITY: A META-ANALYSIS OF PLACEBO-CONTROLLED RANDOMISED CONTROLLED TRIALS
por: Schneider-Thoma, Johannes, et al.
Publicado: (2018)

Response rates in patients with schizophrenia and positive symptoms receiving cognitive behavioural therapy: a systematic review and single-group meta-analysis
por: Bighelli, Irene, et al.
Publicado: (2018)

Planning a future randomized clinical trial based on a network of relevant past trials
por: Salanti, Georgia, et al.
Publicado: (2018)

Long-Acting Injectable Antipsychotics for First-Episode Schizophrenia: The Pros and Cons
por: Kim, Borah, et al.
Publicado: (2012)

Alterations of Intrinsic Connectivity Networks in Antipsychotic-Naïve First-Episode Schizophrenia
por: Anhøj, Simon, et al.
Publicado: (2018)

Living network meta-analysis compared with pairwise meta-analysis in comparative effectiveness research: empirical study
por: Nikolakopoulou, Adriani, et al.
Publicado: (2018)

Relapse Prevention in Schizophrenia: A Systematic Review and Meta-Analysis of Second-Generation Antipsychotics versus First-Generation Antipsychotics
por: Kishimoto, Taishiro, et al.
Publicado: (2011)

CINeMA: An approach for assessing confidence in the results of a network meta-analysis
por: Nikolakopoulou, Adriani, et al.
Publicado: (2020)

A living meta-ecological study of the consequences of the COVID-19 pandemic on mental health
por: Leucht, Stefan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5qd8t9v10g1fjqpt7cvvnhqg0t